BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Total Current Liabilities
All obligations due within one year.
BillionToOne, Inc.NASDAQ: BLLN
Total Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total current liabilities rises 39.8% from a year ago
Total current liabilities stood at $55.73M at the end of Q2 FY2026, up 39.8% from a year earlier and down 2.5% from the prior quarter.
Context
- Total current liabilities amounted to 7.6% of total assets at the end of Q2 FY2026, down 5.1 pp from a year earlier.
- Total current liabilities increased in 1 of the last 2 fiscal years.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +39.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 47.96M USD
- Year-over-year change
- +69.0%
- 2-year CAGR
- -15.3%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47.96M | +69.0% |
| FY2024 | 2024-12-31 | 28.39M | -57.5% |
| FY2023 | 2023-12-31 | 66.8M | — |
Total Current Liabilities vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 total current liabilities of $55.73M is the lowest of the 9 companies compared; the peer median is $98.01M.
- Its year-over-year change of +39.8% is the 3rd highest of 9, against a peer median of +12.0%.
- Total current liabilities amounts to 7.6% of total assets for BLLN, versus a peer median of 11.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $553.2M | +43.7% | +12.4% | 20.8% | |
| Sep 2026 | $373.17M | +57.5% | +16.1% | 19.8% | |
| Mar 2026 | $130.2M | -13.8% | -0.8% | 19.3% | |
| Jun 2026 | $105.88M | +5.8% | -0.6% | 7.8% | |
| Mar 2026 | $90.13M | +36.7% | -1.2% | 7.8% | |
| Jun 2026 | $83.54M | +18.3% | -16.1% | 2.9% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $74.63M | +4.5% | -9.0% | 15.5% |
| Jun 2026 | $62.74M | -17.9% | -1.4% | 4.2% | |
BLLNBillionToOne, Inc. | Jun 2026 | $55.73M | +39.8% | — | 7.6% |
| Peer median (excluding BLLN) | $98.01M | +12.0% | -1.0% | 11.7% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.